Medindia

X

NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit

Tuesday, December 22, 2009 Heart Disease News J E 4
Advertisement
Conference to Discuss the Latest Approaches in the Evaluation of Drugs that Affect Heart Rate, Blood Pressure, QT Prolongation and Other CV Safety Related Issues

Investor Contact:

Hayden IR

Jeff Stanlis, Partner and VP of Communications

(602) 476-1821

jeff@haydenir.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Mylan Receives Tentative FDA Approval Under PEPFAR...
S
While Some Were Counting Sugar Plums...Others Were...